UNSPSC 51313902: Tazanolast

This classification denotes a mast cell stabilizer with the molecular formula C13H15N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T0248823H1, chemically known as acetic acid, oxo((3-(1h-tetrazol-5-yl)phenyl)amino)-, butyl ester but generally known as tazanolast, which bears US NIH Compound Identifier 5380. European Medicines Agency schedules Tazanolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10843MIG.

UNSPSC 51313902 Tazanolast is a Commodity code that covers pharmaceutical products procured by state and local health and human services agencies, though recent solicitations show this code capturing a broader range of pharmaceutical and medication-related procurement activity than the narrow product name suggests. State and local governments are using this code to buy naloxone and drug deactivation systems for community health support, generic multi-source pharmaceuticals through cooperative purchasing arrangements, and to evaluate direct-to-manufacturer prescription fulfillment models. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local governments across multiple states including Oregon).

Recent activity spans multiple regions. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly delivery to the Seminole County Community Health Building and a response deadline of July 26, 2023. The Texas Health and Human Services Commission issued a Request for Information (HHS0017013) on April 3, 2026, to assess vendor capabilities for implementing direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), posted an RFP (S1070000015802) on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring vendors to supply through three authorized wholesalers with a contract start date of July 1, 2026, and evaluation weighted heavily toward price competitiveness (75 percent). All recent solicitations require FDA compliance, Good Manufacturing Practices certification, and comprehensive liability and workers' compensation insurance.